在加拿大争取普及出生剂量乙型肝炎疫苗接种:来自安大略省的数据提出了一个令人信服的案例
Mia J Biondi1,2, Jennifer van Gennip3, Jordan J Feld1
1Viral Hepatitis Care Network (VIRCAN) Study Group, Toronto Centre for Liver Disease, Toronto, Ontario, Canada.
Paediatrics & child health
|September 8, 2025
概括
建议加拿大接种全方位出生剂量乙型肝炎疫苗. 数据显示,加拿大儿童在青少年接种疫苗之前就感染了乙型肝炎病毒 (HBV),这凸显了更新公共卫生政策的必要性.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 世界卫生组织在2009年推了普遍的出生剂量乙型肝炎病毒 (HBV) 疫苗接种.
- 尽管如此,五个加拿大省份仍在继续为青少年接种疫苗,而不是新生儿.
- 国家免疫咨询委员会 (NACI) 建议对疫苗接种计划的变化进行当地流行病学评估.
研究的目的:
- 评估加拿大目前乙型肝炎疫苗接种计划的有效性.
- 提供支持加拿大转向全民出生剂量HBV疫苗接种的证据.
主要方法:
- 分析加拿大儿童的HBV感染率.
- 关于HBV在出生时接种疫苗和没有接种疫苗的地区的流行病学数据的审查.
- 在加拿大背景下评估出生剂量疫苗接种的成本效益.
主要成果:
- 在加拿大出生于12岁以下的儿童在接受青少年疫苗接种之前已经感染了HBV.
- 已建立出生剂量疫苗接种计划的地区显示成人HBV流行率较低.
- 在加拿大,出生剂量乙型肝炎疫苗已被证明具有成本效益.
结论:
- 目前的青少年疫苗接种计划不足以防止加拿大儿童感染HBV.
- 全民出生剂量HBV疫苗接种是加拿大的更有效和更具成本效益的策略.
- 强烈鼓励公共卫生政策制定者和医疗保健提供者制定统一的加拿大关于全民分娩剂量疫苗接种的建议.
相关概念视频
Vaccinations
51.3K
Overview
51.3K
Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Bioequivalence studies: Biowaivers
229
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
229
Bioavailability Study Design: Single Versus Multiple Dose Studies
217
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
217
Cancer Vaccines
976
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
976
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233


